JOHNSON & JOHNSON
Top Portfolio Positions
15 positions ·
$650,121,258 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
2,449,183 | $258,143,888 | 39.71% | |
| NBTX |
Nanobiotix S.A.
Healthcare
|
5,623,816 | $173,607,199 | 26.70% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
6,641,064 | $57,511,614 | 8.85% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
1,784,517 | $55,837,536 | 8.59% | |
| CVRX |
CVRx, Inc.
Healthcare
|
4,024,861 | $38,075,185 | 5.86% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
1,979,173 | $25,847,999 | 3.98% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
814,586 | $14,735,860 | 2.27% | |
| XNCR |
Xencor Inc
Healthcare
|
748,062 | $9,021,627 | 1.39% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
357,939 | $8,952,054 | 1.38% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
3,379,064 | $4,054,876 | 0.62% |
Portfolio Trend
19 quarters · across all stocks
Holdings in ACET
Shares Held
Position Value (USD)
2 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $155,124 | 22,779 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $191,799 | 22,779 | Shares | Defined | 2026-03-18 | |
| No 13F history on record for this holder in this stock. | ||||||